Clinical Trial: Colipral(R) (Probiotic Strain Escherichia Coli 5C (ECP24(R))) for Prevention of Recurrent Cystitis in Menopausal Women

U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07676604) titled 'Colipral(R) (Probiotic Strain Escherichia Coli 5C (ECP24(R))) for Prevention of Recurrent Cystitis in Menopausal Women' on June 24.

Brief Summary: Recurrent cystitis is a common condition in menopausal women and is associated with impaired quality of life and increased antibiotic use. This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the efficacy and safety of Colipral(R) in preventing recurrent cystitis in menopausal women. Participants will be randomized to receive either Colipral(R) (probiotic strain Escherichia coli 5C (ECP24(R))))or placebo for 12 weeks and will be followed for a total of 24 weeks...